LexDanaLexDanabeta
Inventor

MARK TORNETTA

Inventor
US

Overview

2→
Patents
2023–2024
Patent span
Human necessities
Primary field (CPC A)

Patents· 2 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Kprimary
A61KPreparations for medical, dental or toiletry purposes20%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations20%
C07KPeptides20%
C12RIndexing scheme associated with subclasses c12c - c12q, relating to microorganisms20%
Y02ATechnologies for adaptation to climate change20%
PatentTitleYear
11,884,722Anti-GPRC5D antibodies, bispecific antigen binding molecules that bind GPRC5D and CD3, and uses thereof202411,685,777Anti-GPRC5D antibodies, bispecific antigen binding molecules that bind GPRC5D and CD3, and uses thereof2023

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

2023Patents assigned to JANSSEN PHARMACEUTICA NV (1)· patent assignee history
2023–2024Based in US· patent location history
2024Patents assigned to JANSSEN BIOTECH INC (1)· patent assignee history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
JANSSEN BIOTECH INC12024
JANSSEN PHARMACEUTICA NV12023
Locations
LocationPatentsSpan
US22023–2024